Base-Promoted [4 + 3] Cycloadditions Enabling the Construction of Polycycle-Fused Uracils from N -Aminoisoquinolinium Derivatives
Organic Letters · 23.01.2026 · 28 (3) · 960-965
DOI: 10.1021/acs.orglett.5c04929 ↗Kurz gefasst
Fachartikel in der Zeitschrift Organic Letters, online erschienen am 13.01.2026. Verfasst von Wen-Rong Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Drug Research and Development, Guangdong Pharmaceutical University, Guangzhou 510006, P. R. China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Guangdong Pharmaceutical University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Center for Drug Research and Development, Guangdong Pharmaceutical University, Guangzhou 510006, P. R. China.
- School of Chemistry and Chemical Engineering, Guangdong Pharmaceutical University, Guangzhou 510006, P. R. China.
ORCID-Profile: Xiang Liu, Pengju Feng, Shang-Shi Zhang
Förderung
- Guangdong Pharmaceutical University
Zitieren
APA
Wu, W. R., Meng, Y. J., Chen, J., Yang, Z. F., Liu, X. X., Liu, X., Feng, P., & Zhang, S. S. (2026). Base-Promoted [4 + 3] Cycloadditions Enabling the Construction of Polycycle-Fused Uracils from N -Aminoisoquinolinium Derivatives. Organic Letters, 28(3), 960-965. https://doi.org/10.1021/acs.orglett.5c04929
Vancouver
Wu WR, Meng YJ, Chen J, Yang ZF, Liu XX, Liu X, et al. Base-Promoted [4 + 3] Cycloadditions Enabling the Construction of Polycycle-Fused Uracils from N -Aminoisoquinolinium Derivatives. Organic Letters. 2026;28(3):960-965. doi:10.1021/acs.orglett.5c04929
BibTeX
@article{Wu2026,
author = {Wu, Wen-Rong and Meng, Yuan-Jie and Chen, Juan and Yang, Zi-Feng and Liu, Xin-Xing and Liu, Xiang and Feng, Pengju and Zhang, Shang-Shi},
title = {Base-Promoted [4 + 3] Cycloadditions Enabling the Construction of Polycycle-Fused Uracils from N -Aminoisoquinolinium Derivatives},
journal = {Organic Letters},
year = {2026},
volume = {28},
number = {3},
pages = {960--965},
doi = {10.1021/acs.orglett.5c04929}
}
EUVIMED